Knott David M Jr »

Revance Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2024-09-30 $163k 31k 5.20

More positions owned by Knott David M Jr

Calumet Specialty Products Partners Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
AllianceBernstein Holding Common (AB)
Panagram BBB-B CLO ETF Common (CLOZ)
DocGo Common (DCGO)
AbbVie Common (ABBV)
Pfizer Common (PFE)
Apple Common (AAPL)
Medical Facilities Corp Common (MFCSF)
Verona Pharma Common (VRNA)
OmniAB Common (OABI)
Invesco AAA Floating Rate Note ETF Common (ICLO)
Ardelyx Common (ARDX)
JPMorgan Chase & Co. Common (JPM)

View all positions for Knott David M Jr

Top funds holding Revance Therapeutics

BlackRock
Beryl Capital Management
Vanguard Group
Fil
Alliancebernstein
Squarepoint Ops
Magnetar Financial
State Street Corporation
Alpine Associates Management
Geode Capital Management
Boothbay Fund Management
Glazer Capital
Newtyn Management
Omni Event Management
Adage Capital Partners GP

View all funds holding Revance Therapeutics